类风湿关节炎完全与可接受症状缓解:基于Okomarigoto表的PASS阈值
横断面研究纳入370例类风湿关节炎(RA)患者(其中213例达SDAI缓解),以患者可接受症状状态(PASS)为外部锚定,用第75百分位法与ROC分析确定Okomarigoto表(OS)残余症状阈值。全体队列OS阈值定为3、SDAI缓解亚组为2,ROC区分度良好(AUC 0.824与0.838)。
要点
- 全体RA患者OS阈值3、SDAI缓解者阈值2,可作为可接受残余症状的参考界值
- OS分层越高报告PASS者比例越低,全体队列与SDAI缓解亚组均P<0.0001
- OS评分越低者躯体功能(HAQ-DI)越好、PGA评分越低
核心结论
- OS定义的症状缓解为评估RA可接受残余症状负担提供了有临床意义的框架。
- OS评估可补充传统缓解标准,支持更以患者为中心的治疗策略。
研究设计与样本
- 横断面研究,纳入370例RA患者,其中213例达到SDAI缓解。
- 残余症状用Okomarigoto表(OS)评估,以PASS为外部锚定,阈值采用第75百分位法确定并用ROC分析评价。
主要发现
- 370例中284例报告PASS。
- 第75百分位法确定的OS阈值为全体队列3、SDAI缓解患者2。
- ROC分析显示对报告PASS者的区分度良好,AUC分别为0.824与0.838。
- 随OS类别升高,报告PASS者比例在全体队列为95.2%、83.9%、46.8%(P<0.0001),在SDAI缓解亚组为99.0%、95.7%、71.4%(P<0.0001)。
- OS评分较低者躯体功能较好且PGA评分较低。
关键数值与推荐
- 全体队列OS可接受症状阈值:3。
- SDAI缓解亚组OS可接受症状阈值:2。
- ROC区分报告PASS者AUC:全体0.824、SDAI缓解亚组0.838。
- OS类别间PASS比例差异均P<0.0001。
临床怎么用
- 对已达临床缓解的RA患者可用OS进一步评估残余症状,并结合PASS阈值判断症状是否可接受。
- OS评分高于相应阈值(全体3、SDAI缓解者2)提示残余症状负担可能不可接受,需关注功能与患者整体评价。
局限性
- 为横断面研究,未体现OS阈值对纵向结局的预测价值。
- PASS与OS阈值的有效性仍需外部人群验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Residual symptoms frequently persist despite clinical remission in RA. Although complete absence of residual symptoms is associated with favorable outcomes, an acceptable level of residual symptoms has not been defined. This study aimed to establish clinically meaningful thresholds for residual symptoms assessed by the Okomarigoto Sheet (OS) and to evaluate their clinical validity using the Patient Acceptable Symptom State (PASS). METHODS: This cross-sectional study included 370 patients with RA, including 213 who achieved Simplified Disease Activity Index (SDAI) remission. Residual symptoms were assessed using the OS, and PASS was used as an external anchor. OS thresholds were determined using the 75th percentile method and evaluated by Receiver Operator Characteristic (ROC) analysis. Clinical validity was assessed by the proportion of patients reporting PASS, Health Assessment Questionnaire-Disability Index (HAQ-DI), and patient global assessment (PGA). RESULTS: Among 370 patients, 284 reported PASS. The 75th percentile method identified OS thresholds of 3 in the overall cohort and 2 among patients achieving SDAI remission. ROC analysis demonstrated good discrimination for patients reporting PASS (AUC 0.824 and 0.838, respectively). The proportion of patients reporting PASS decreased across increasing OS categories in both the overall cohort (95.2%, 83.9% and 46.8%; P < 0.0001) and the SDAI remission subgroup (99.0%, 95.7% and 71.4%; P < 0.0001). Lower OS scores were also associated with better physical function and lower PGA scores. CONCLUSION: OS-defined symptom remission provides a clinically meaningful framework for evaluating acceptable residual symptom burden in RA. Assessment with the OS may complement conventional remission criteria and support more patient-centred treatment strategies.
引用
- Koyama K, Ohba T, Koizumi R, et al. Complete and acceptable symptom remission in rheumatoid arthritis: PASS-based thresholds derived from the Okomarigoto Sheet. Rheumatology (Oxford). 2026. PMID: 42714934. doi:10.1093/rheumatology/keag491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。